Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2011 1
2013 1
2015 2
2016 2
2017 5
2018 3
2019 2
2020 3
2021 9
2022 12
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations.
Wang M, Yang JC, Mitchell PL, Fang J, Camidge DR, Nian W, Chiu CH, Zhou J, Zhao Y, Su WC, Yang TY, Zhu VW, Millward M, Fan Y, Huang WT, Cheng Y, Jiang L, Brungs D, Bazhenova L, Lee CK, Gao B, Xu Y, Hsu WH, Zheng L, Jänne PA. Wang M, et al. Among authors: nian w. Cancer Discov. 2022 Jul 6;12(7):1676-1689. doi: 10.1158/2159-8290.CD-21-1615. Cancer Discov. 2022. PMID: 35404393 Free PMC article.
Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer.
Liang L, Zhang Y, Li C, Liao Y, Wang G, Xu J, Li Y, Yuan G, Sun Y, Zhang R, Li X, Nian W, Zhao J, Zhang Y, Zhu X, Wen X, Cai S, Li N, Wu L. Liang L, et al. Among authors: nian w. EBioMedicine. 2022 Sep;83:104222. doi: 10.1016/j.ebiom.2022.104222. Epub 2022 Aug 13. EBioMedicine. 2022. PMID: 35973389 Free PMC article.
Evaluation of Safety of Treatment With Anti-Epidermal Growth Factor Receptor Antibody Drug Conjugate MRG003 in Patients With Advanced Solid Tumors: A Phase 1 Nonrandomized Clinical Trial.
Qiu MZ, Zhang Y, Guo Y, Guo W, Nian W, Liao W, Xu Z, Zhang W, Zhao HY, Wei X, Xue L, Tang W, Wu Y, Ren G, Wang L, Xi J, Jin Y, Li H, Hu C, Xu RH. Qiu MZ, et al. Among authors: nian w. JAMA Oncol. 2022 Jul 1;8(7):1042-1046. doi: 10.1001/jamaoncol.2022.0503. JAMA Oncol. 2022. PMID: 35511148 Free PMC article. Clinical Trial.
Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study.
Qiao G, Zhuang W, Dong B, Li C, Xu J, Wang G, Xie L, Zhou Z, Tian D, Chen G, Tang J, Zhou H, Zhang D, Shi R, Chen R, Nian W, Zhang Y, Zhao J, Wen X, Xu Y, Li B, Zhang Z, Cai S, Ben X, Qi Y. Qiao G, et al. Among authors: nian w. BMC Med. 2021 Oct 13;19(1):243. doi: 10.1186/s12916-021-02109-y. BMC Med. 2021. PMID: 34641873 Free PMC article. Clinical Trial.
Electrochemical Biosensors for Circulating Tumor DNA Detection.
Wang K, Peng Z, Lin X, Nian W, Zheng X, Wu J. Wang K, et al. Among authors: nian w. Biosensors (Basel). 2022 Aug 17;12(8):649. doi: 10.3390/bios12080649. Biosensors (Basel). 2022. PMID: 36005048 Free PMC article. Review.
Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma.
Luo B, Ma F, Liu H, Hu J, Rao L, Liu C, Jiang Y, Kuangzeng S, Lin X, Wang C, Lei Y, Si Z, Chen G, Zhou N, Liang C, Jiang F, Liu F, Dai W, Liu W, Gao Y, Li Z, Li X, Zhou G, Li B, Zhang Z, Nian W, Luo L, Liu X. Luo B, et al. Among authors: nian w. BMC Med. 2022 Jan 14;20(1):8. doi: 10.1186/s12916-021-02201-3. BMC Med. 2022. PMID: 35027051 Free PMC article.
Blood-based DNA methylation profiling for the detection of ovarian cancer.
Li N, Zhu X, Nian W, Li Y, Sun Y, Yuan G, Zhang Z, Yang W, Xu J, Lizaso A, Li B, Zhang Z, Wu L, Zhang Y. Li N, et al. Among authors: nian w. Gynecol Oncol. 2022 Nov;167(2):295-305. doi: 10.1016/j.ygyno.2022.07.008. Epub 2022 Sep 10. Gynecol Oncol. 2022. PMID: 36096974
44 results